Literature DB >> 25866319

Factors associated with the presentation of moyamoya in childhood.

Catherine Amlie-Lefond1, Richard G Ellenbogen2.   

Abstract

BACKGROUND: Moyamoya accounts for approximately one fifth of cerebral arteriopathies in children presenting with acute stroke; however, often is not diagnosed until stroke occurs, even in higher risk populations and often despite a history of transient ischemic attacks (TIAs). This study was undertaken to better define which groups of children are at risk for moyamoya and how they present.
METHODS: With institutional review board approval, the charts of all patients with a diagnosis of moyamoya were reviewed.
RESULTS: Fifty-four patients were identified. Mean age at presentation was 7.5 years; 56% were female; 32 (59%) had predisposing medical conditions associated with moyamoya; and 17 (31%) were of Asian descent. Only 11 children (20%) had no underlying predisposing condition identified, of whom, 4 had underlying conditions not previously reported in association with moyamoya. Eight patients (15%) were Native American; 38 (70%) had a history of TIAs; and 26 (48%) presented with acute stroke, of whom, three fourth had left and one fourth had right hemisphere strokes. Fifty-two percent had a history of headache.
CONCLUSIONS: Most children with moyamoya in this series had an underlying predisposing condition, compared with other US series, where almost half had no predisposing condition identified. In this series, fewer children (48% versus 68%) presented with stroke, many (70% versus 43%) had a history of TIAs, and many (52% versus 22%) had a history of headaches than in previous reports. In addition, the Native American population may be at higher risk of moyamoya than previously recognized.
Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Moyamoya; childhood; stroke; transient ischemic attack

Mesh:

Year:  2015        PMID: 25866319     DOI: 10.1016/j.jstrokecerebrovasdis.2015.01.018

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  Factors Associated with Clinical Outcomes in Patients with Primary Intraventricular Hemorrhage.

Authors:  Sang-Hoon Lee; Kyung-Jae Park; Dong-Hyuk Park; Shin-Hyuk Kang; Jung-Yul Park; Yong-Gu Chung
Journal:  Med Sci Monit       Date:  2017-03-22

2.  Moyamoya disease in a Moroccan baby: a case report.

Authors:  Abdelhafid Houba; Nisrine Laaribi; Mohammed Meziane; Abdelhamid Jaafari; Khalil Abouelalaa; Mustapha Bensghir
Journal:  J Med Case Rep       Date:  2018-06-13

Review 3.  [Stroke alarm-Arterial ischemic stroke as one of the most time-critical emergencies in children and adolescents].

Authors:  Lucia Gerstl; M Olivieri; F Heinen; C Bidlingmaier; A S Schroeder; K Reiter; F Hoffmann; K Kurnik; T Liebig; C G Trumm; N A Haas; A Jakob; I Borggraefe
Journal:  Nervenarzt       Date:  2022-01-24       Impact factor: 1.297

4.  Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort.

Authors:  Chiara Po'; Margherita Nosadini; Marialuisa Zedde; Rosario Pascarella; Giuseppe Mirone; Domenico Cicala; Anna Rosati; Alessandra Cosi; Irene Toldo; Raffaella Colombatti; Paola Martelli; Alessandro Iodice; Patrizia Accorsi; Lucio Giordano; Salvatore Savasta; Thomas Foiadelli; Giuseppina Sanfilippo; Elvis Lafe; Federico Zappoli Thyrion; Gabriele Polonara; Serena Campa; Federico Raviglione; Barbara Scelsa; Stefania Maria Bova; Filippo Greco; Duccio Maria Cordelli; Luigi Cirillo; Francesco Toni; Valentina Baro; Francesco Causin; Anna Chiara Frigo; Agnese Suppiej; Laura Sainati; Danila Azzolina; Manuela Agostini; Elisabetta Cesaroni; Luigi De Carlo; Gabriella Di Rosa; Giacomo Esposito; Luisa Grazian; Giovanna Morini; Francesco Nicita; Francesca Felicia Operto; Dario Pruna; Paola Ragazzi; Massimo Rollo; Alberto Spalice; Pasquale Striano; Aldo Skabar; Luigi Alberto Lanterna; Andrea Carai; Carlo Efisio Marras; Renzo Manara; Stefano Sartori
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.418

5.  Filamin A Variant as a Possible Second-Hit Gene Promoting Moyamoya Disease-like Vascular Formation Associated With RNF213 p.R4810K Variant.

Authors:  Yasuhito Ikeuchi; Jiro Kitayama; Noriyuki Sahara; Takuya Okata; Noriko Miyake; Naomichi Matsumoto; Takanari Kitazono; Tetsuro Ago
Journal:  Neurol Genet       Date:  2022-09-09

6.  Atypical presentation of moyamoya disease with pulmonary hypertension: A case report.

Authors:  Mete Han Kızılkaya; Fahrettin Uysal; Emre Gürbüz; Mevlüt Özgür Taşkapılıoğlu; Özlem Mehtap Bostan
Journal:  Anatol J Cardiol       Date:  2018-05       Impact factor: 1.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.